Massengill Advisory LLC
+1 (503) 370-4028
  • Private Equity
  • Majority Recapitalization
  • Media
  • About
  • Terms of Use
  • Privacy Policy

Leadership


Picture

Kevin W. Massengill, Managing Director

Kevin W. Massengill is the Managing Director of Massengill Advisory LLC a Florida-based business consultancy and family office managing investments in hard assets and private equity. 
​Massengill is also the Executive Chairman of Meraglim Holdings Corporation​, a Delaware company. An AI investment holding company, Meraglim® created the world's leading Raven Predictive Analytics® a patent-pending enterprise SaaS combining AI, complexity science and human intelligence for institutional investors and corporate leaders.

​​Massengill is also the Chairman of the Board for six different acquisition focused QLA investment companies: a Dutch NEWCO (construction), 
Northstar Security Holdings, Nutraceutical Holdings, RecordAI (healthcare technology), United Pain Clinics, and Vernal Partners, Inc. (healthcare facilities).
​
A retired U.S. Army officer and former senior defense executive with Fortune 500 companies Raytheon (NYSE: RTX) and Leidos (NYSE: LDOS), Massengill also served as a managing director of Silver Leaf Partners, a boutique New York investment bank.

​
Massengill has previously served as Chairman of the Board for the Leidos (NYSE: LDOS) operating businesses in Australia, Saudi Arabia and the United Kingdom, a member of the Overseas Schools Advisory Council for the U.S. Department of State - D.C., a Non Executive Board Director for GrowthGate Capital, a private equity buy out firm in Dubai, and as Chairman of the Board of Trustees for the American Community School - Abu Dhabi.​

Massengill holds an MA in Near Eastern Studies from Princeton University, a BA in Russian Area Studies from the University of Missouri-Columbia where he was a Distinguished Military Graduate and awarded a US Army Top 5% Fellowship. He has completed the International Directors Program at INSEAD Fontainebleau, the Program on Negotiation for Senior Executives at Harvard Law School and held FINRA Series 7 and Series 63 licenses.

Next Step:

If you are the owner of a business with $5m to $50m in revenue and you are looking for a safe pair of hands to protect your legacy, brand and employees, you have nothing to lose by having a quick conversation. Click the button below to schedule a call.
Click Here to Schedule a Call

Follow Kevin Massengill at...

"Gold is not a drug that cures the disease but merely a symbol of the flight from dishonesty - a symbol of independence, honest money and permanence."  - Anthony Deden ​
Picture
Powered by Create your own unique website with customizable templates.